Bluejay Diagnostics Inc (BJDX)

NASDAQ
1.13
+0.01(+0.89%)
After Hours
1.15
+0.02(+1.77%)
- Real-time Data
  • Volume:
    55,035
  • Day's Range:
    1.10 - 1.14
  • 52 wk Range:
    0.82 - 6.25

BJDX Overview

Prev. Close
1.12
Day's Range
1.1-1.14
Revenue
249K
Open
1.1
52 wk Range
0.82-6.25
EPS
-0.4
Volume
55,035
Market Cap
22.77M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
997,686
P/E Ratio
-2.90
Beta
-
1-Year Change
-
Shares Outstanding
20,152,344
Next Earnings Date
Nov 30, 2022
What is your sentiment on Bluejay Diagnostics?
or
Market is currently closed. Voting is open during market hours.

Bluejay Diagnostics Inc Company Profile

Bluejay Diagnostics Inc Company Profile

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralStrong SellStrong SellSell
Technical IndicatorsStrong BuyStrong BuySellStrong SellNeutral
SummaryBuyBuyStrong SellStrong SellNeutral
  • 🚀🚀🚀🚀
    0